Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors

Introduction: Renal cell carcinoma (RCC) with sarcomatoid component carries a poor prognosis. Immune checkpoint inhibitors (CPIs) have been approved for the treatment of metastatic RCC, but their efficacy in patients with sarcomatoid component is not known. Materials and Methods: We conducted a retr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: Hanif, Ahmad, Pandey, Manu, Khan, Sumera, Attwood, Kristopher, George, Saby
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2019
Témata:
Brief Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6682356/
https://ncbi.nlm.nih.gov/pubmed/31413914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1606639
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky